Skip to main content

Table 3 CRPS participants reported higher scores for pain, anxiety depression, stress, pain catastrophising and kinesiophobia, as well as reduced pain self-efficacy compared to healthy controls. A table showing participant information, pain and psychological measures in CRPS participants and healthy controls. Visual analogue scale (VAS), Short-form Depression, Anxiety and Stress scale (DASS21), Short-form McGill Pain Questionnaire (SF-MPQ-2), Tampa Scale for Kinesiophobia (TSK) and Pain Catastrophising Scale (PCS), Pain Self-efficacy Questionnaire (PSEQ). N = 14 CRPS and N = 14 controls. All data are presented as group means (± S.E.M.). ** represents P < 0.01, *** represents P < 0.001 in in a Mann-Whitney U test

From: Expansion and activation of distinct central memory T lymphocyte subsets in complex regional pain syndrome

 

Control ± S.E.M.

CRPS ± S.E.M.

Sex (F/M)

5/9

10/4

Age (years)

39.21 ± 3.3

46.14 ± 4.2

CRPS type (I/II)

 

14/0

Time since onset (years)

 

4.13 ± 1.6

Limb affected (upper/lower)

 

7/7

CRPS trigger (fracture/soft tissue injury/surgery)

 

7/4/3

Pain score (VAS 0–100)

7.6 ± 1.1

69.36 ± 3.7***

DASS 21 (0–42)

Depression

2.8 ± 1.2

11.14 ± 2.8**

Anxiety

3.0 ± 0.8

14.00 ± 2.0***

Stress

5.8 ± 1.8

17.58 ± 2.0***

SF-MPQ-2 (0–220)

4.8 ± 2.0

113.71 ± 11.0***

PCS (0–52)

3.2 ± 1.6

21.57 ± 2.8***

PSEQ (60–0)

57.4 ± 1.1

24.07 ± 2.9***

TSK (0–68)

29.1 ± 1.6

39.79 ± 1.3***